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A B S T R A C T We have studied the interaction be-
tween virulent egg yolk-grown Legionella pneumophila
Philadelphia 1 and human blood monocytes in vitro.
The leukocytes were cultured in antibiotic-free tissue
culture medium supplemented with 15% autologous
human serum.
L. pneumophila multiplied several logs, as measured
by colony-forming units, when incubated with mono-
cytes or mononuclear cells; the mid-log phase doubling
time was 2 h. The level to which L. pneumophila mul-
tiplied was proportional to the number ofmononuclear
cells in the culture. L. pneumophila multiplied only
in the adherent fraction of the mononuclear cell pop-
ulation indicating that monocytes but not lymphocytes
support growth of the bacteria. Peak growth ofL. pneu-
mophila was correlated with destruction of the mono-
cyte monolayer. By fluorescence microscopy using
fluorescein conjugated rabbit anti-L. pneumophila anti-
serum, the number of monocytes containing L. pneu-
mophila increased in parallel with bacterial growth
in the culture. At the peak of infection, monocytes were
packed full with organisms. By electron microscopy,
L. pneumophila in such monocytes were found in mem-
brane-bound cytoplasmic vacuoles studded with struc-
tures resembling host cell ribosomes.
Several lines of evidence indicate that L. pneumo-
phila grows within monocytes. (a) In the absence of
leukocytes, L. pneumophila did not grow in tissue cul-
ture medium with or without serum even ifthe medium
was conditioned by monocytes. (b) L. pneumophila
did not grow in sonicated mononuclear cells. Lysis of
these cells at various times during logarithmic growth
of L. pneumophila was followed by cessation of bac-
terial multiplication. Growth resumed when intact
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mononuclear cells were added back to the culture. (3)
In parabiotic chambers separated by 0. 1-,um Nuclepore
filters, L. pneumophila multiplied only when placed
on the same side of the filter as mononuclear cells.
These findings indicate that L. pneumophila falls into
a select category of bacterial pathogens that evade host
defenses by parasitizing monocytes. It remains to be
determined whether cell-mediated immunity plays a
dominant role in host defense against L. pneumophila
as it does against other intracellular pathogens.
INTRODUCTION
Legionnaires' disease entered our lexicon when it
struck 221 people, mostly American Legionnaires, and
claimed 34 lives in Philadelphia in July 1976 (1, 2).
Since then, we have learned that the disease is newly
recognized but not new (3, 4), and that it occurs world-
wide in epidemic and endemic forms (4-8). It is ap-
parently a major cause of pneumonia in the United
States (9, 10) and responsible for a substantial pro-
portion of fatal nosocomial pneumonia (11, 12). It
affects all age groups, but particularly people over 30
yr, and men more often than women (8, 13). It has a
predilection for people who smoke or abuse alcohol,
travellers, construction workers, and immunocom-
promised patients (6, 10, 14-16), and it is probably
spread by the airborne route (10). The case-fatality rate
has been in the 15-20% range (10, 17).
The causative agent of Legionnaires' disease, Le-
gionella pneumophila is an aerobic gram-negative bac-
terium with fastidious growth requirements. It was
originally isolated in guinea pigs and embryonated
hens' eggs by a procedure designed for the isolation of
rickettsia (2) but it can now be grown on synthetic
culture media (18).
Although much has been learned about the epi-
demiology and clinical features of Legionnaires' dis-
ease and the properties of the causative agent, the
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immunobiology of the disease and the roles of cellular
and humoral immunity remain poorly understood. Cen-
tral to an understanding of these immunological issues
is the categorization of the Legionnaires' bacillus as
an intracellular or extracellular parasite.
Certain features of Legionnaires' disease suggested
to us that L. pneumophila might be a facultative
intracellular pathogen. First, in lung specimens from
patients with Legionnaires' disease, clusters of bac-
teria have been observed in alveolar macrophages
(19, 20). Similar findings have been reported in the
lungs ofexperimentally infected guinea pigs (21). From
these observations, however, it cannot be determined
whether the bacteria multiplied intracellularly or were
phagocytosed after extracellular multiplication. Sec-
ondly, L. pneumophila was originally isolated by pro-
cedures designed for the isolation of rickettsia, which
are obligate intracellular parasites. Growth on synthetic
medium is fastidious.
We have examined the interaction of virulent egg
yolk-grown L. pneumophila Philadelphia 1 and human
blood monocytes in vitro under antibiotic-free condi-
tions. We used egg yolk-grown organisms because of
the evidence that agar-adapted bacteria lose their viru-
lence for chicken embryos and guinea pigs (22). In
this paper, we shall present our evidence that L. pneu-
mophila multiplies intracellularly in human blood
monocytes and thus should be categorized as a faculta-
tive intracellular parasite.
METHODS
Reagents. Potassium phosphate dibasic (K2HPO4 -3H20),
potassium phosphate monobasic (KH2PO4), sodium phosphate
dibasic anhydrous (Na2HPO4), and sodium phosphate mono-
basic (NaH2PO4 - H20), all analytical reagents (Mallinckdrodt,
Inc., St. Louis, Mo.); L-cysteine hydrochloride * H20, glycerol,
and sodium chloride, all reagent grade (Fisher Scientific
Co., Pittsburgh, Pa.); Bacto-agar and yeast extract (Difco
Laboratories, Detroit, Mich.); activated charcoal acid washed
with phosphoric and sulfuric acids (Sigma Chemical Co.,
St. Louis, Mo.); ferric pyrophosphate soluble (Center for
Disease Control, Atlanta, Ga.).
Media. RPMI 1640 with L-glutamine (Gibco Laboratories,
Grand Island Biological Co., Grand Island, N. Y.); egg yolk
buffer (EYB)l consisted of 12 parts 0.15 M KH2PO4, 38 parts
0.15 M Na2HPO4, 50 parts 0.85% NaCl, pH 7.2 as described
(23); 100 ml of EYB with 1% bovine serum albumin contained
0.3 ml of a 35% solution of bovine serum albumin (Miles
Laboratories, Inc., Elkhart, Ind.). No antibiotics were used
in any medium in any of the experiments.
Serum. Venous blood was clotted in siliconized glass test
tubes, stored for 1 h at room temperature and an additional
1 h at 4°C, and the normal serum separated and stored at
-700C until use as described (24). Autologous serum was used
in all experiments. The serum was negative for anti-L.
pneumophila antibody by the indirect immunofluorescence
test (25).
'Abbreviations used in this paper: CFU, colony-forming
units; CYE, modified charcoal yeast extract agar; EYB, egg
yolk buffer.
Culture of L. pneumophila in embryonated hens' eggs.
L. pneumophila from a single batch of eggs were used in all
the experiments in this study. 6-d-old embryonated hens'
eggs from chickens fed an antibiotic-free diet were injected
with 0.4 ml of a 10-3 dilution in EYB of a 0.2% homogenate
of spleen from a guinea pig that had died after intraperitoneal
inoculation with L. pneumophila Philadelphia 1; the 0.2%
splenic homogenate was obtained from the Center for Disease
Control. Infected yolk sacs from embryos dying 4-8 d after
infection were harvested as described (26), homogenized in
10 ml of EYB, flash-frozen in an alcohol/dry ice bath, and
stored in 1-ml aliquots at -70°C. Cultures from each egg were
tested for viability by culture on complete charcoal-yeast
extract agar, and for the presence of contaminants by culture
on CYE agar without cysteine, tryptic soy broth agar, and
5% sheep blood tryptic soy broth agars, none ofwhich support
the growth of L. pneumophila; all cultures were positive
only on complete charcoal-yeast extract agar. Cultures from
each egg were also treated for L. pneumophila by the direct
fluorescent antibody assay (27) and by staining by the
Gimenez method (26). After quick-thawing, these chicken
embryo cultures contained 5-10 x 106 colony-forming units
(CFU)/ml on modified charcoal-yeast extract agar.
Partial purification of chicken embryo cultures of L.
pneumophila by differential centrifugation. 1-ml aliquots
of chicken embryo cultures were quick-thawed, diluted in
10 ml EYB, and centrifuged at 45 g for 10 min at 4°C; the
large debris was pelleted but L. pneumophila and egg yolk
lipid remained in the supemate under these conditions. L.
pneumophila were pelleted by centrifugation of the super-
nate at 1,800 g for 20 min at 4°C; most of the lipid remained
with the supernate. The bacteria were washed twice more in
RPMI by centrifugation at 1,800 g for 20 min at 4°C. These
partially purified L. pneumophila were used in all experiments.
Modified charcoal-yeast extract agar (CYE). CYE agar
in 100 x 15 mm bacteriologic petri dishes was prepared
as described (18) except that a buffer consisting of 5.24
g/liter K2HPO4 -3H20 and 1.0 g/liter KH2PO4 was added to
maintain pH at 6.9.
Determination of L. pneumophila CFU. Test samples
were serially diluted in EYB with 1% bovine serum albumin
and 100 ,ul of appropriate dilutions spread onto 100 x 15 mm
CYE agar plates with a glass spreader. The plates were
incubated in candle jars at 37°C for 96 h and colonies
counted manually.
Human blood mononuclear cells. Heparinized blood was
diluted 1:1 in 0.9% saline and the mononuclear cell fraction
obtained by centrifugation at 800 g for 30 min at 24°C over a
Ficoll-sodium diatrizoate solution (Ficoll-Paque, Pharmacia
Fine Chemicals, Inc., Piscataway, N. J.) as described (28).
The layer containing the mononuclear cell fraction was
removed, diluted 1:1 in RPMI and the mononuclear cells
collected by centrifugation at 400 g for 10 min at 4°C. To
remove most of the residual platelets, the mononuclear cells
were washed two or three times in RPMI by centrifugation
at 115 g for 10 min at 4°C. The cells were resuspended in
RPMI, counted in a hemocytometer (Clay Adams Div., Becton,
Dickinson & Co., Parsippany, N. J.) and adjusted to the
required concentration. The cells were >99% viable by trypan
blue exclusion. A sample of the cell suspension was cyto-
centrifuged and stained; the cell population contained
-1.5% polymorphonuclear leukocytes, 40% monocytes, and
58.5% lymphocytes.
Selection of adherent and nonadherent subpopulations
of mononuclear cells. Mononuclear cells (5 x 106) in RPMI
and 15% serum were incubated in 35-mm Falcon plastic
petri dishes (Falcon Labware, Div. Becton, Dickinson &
Co., Oxnard, Calif.) for 1 h at 37°C in 5% C02-95% air. The
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adherent subpopulation (2.2 x 106 cells) consisted of that
fraction of the mononuclear cells that adhered to the petri
dish during this incubation and remained adherent after the
supernate was removed and the petri dish was vigorously
washed in RPMI (37°C). The nonadherent subpopulation
(2.2 x 106 cells) consisted of that fraction of the same mono-
nuclear cell population that did not adhere to petri dishes
after three successive 1-h incubations (including the one used
to select the adherent fraction) at 37°C in 5% C02-95% air.
The number of adherent cells on each petri dish was
determined by counting the number of cells within a cali-
brated area using an inverted phase contrast microscope.
Cell counts from different sections of each petri dish
were averaged.
Infection of mononuclear cells in suspension. In experi-
ments in which monocytes were plated after infection (Fig.
IB, 2), L. pneumophila (-4 x 107 CFU) were mixed with
2 x 107 mononuclear cells (containing -8 x 106 monocytes
for a CFU:monocyte ratio of 5:1) in 2 ml RPMI and 15%
serum in 17 x 100 mm plastic tubes (2057, Falcon Labware);
the tubes were gased with 5% C02-95% air mixture, sealed
with Parafilm (American Can Co., Greenwich, Conn.), and
shaken at 37°C for 30 min on a gyratory shaker at 200 rpm.
100 ,1. of this suspension was plated on 13 mm Diam glass
coverslips for 1 h at 370C in 5% C02-95% air; during this
incubation, the monocytes adhered to and spread out on the
coverslips. The coverslips (two or three per 35-mm petri
dish) were then washed with RPMI (22°C) to remove non-
adherent bacteria and leukocytes and the infected mono-
layers were incubated in 2 ml RPMI and 15% serum at
370C in 5% C02-95% air.
In experiments in which monocytes were maintained in
17 x 100-mm plastic tubes after infection, various numbers
of L. pneumophila and mononuclear cells at the concentra-
tions indicated were incubated together for 1 h under the
same conditions as above. Afterward, the Parafilm was
removed and the loosely capped tubes were held at 370C in
5% C02-95% air under stationary conditions.
Culture of L. pneumophila and mononuclear cells in
parabiotic chambers. Six Karush-type parabiotic chambers
(Bellco Glass, Inc., Vineland, N. J.) with 0.05- or 0.1-ym
Nuclepore filters separating the two compartments of each
chamber (Nuclepore Corp., Pleasanton, Calif.) were mounted
on Bellco 3-set chamber holders. The junction of each
chamber was sealed with a water-insoluble silicone lubricant
(high vacuum grease, Dow Coming Corp., Midland, Mich.)
and the opening to each compartment of each chamber was
capped with sterile Swinnex 13-mm millipore filter holders
(Millipore Corp., Bedford, Mass.) packed with cotton. The
entire apparatus was sterilized by autoclaving, after which
the junction connecting the two compartments of each
chamber was wrapped with Parafilm as an additional pre-
caution against leakage. 1.5 x 106 mononuclear cells in RPMI
were placed in one compartment of each of the six chambers;
3 x 104 L. pneumophila in RPMI were placed in the compart-
ment on the same side of the filter as the mononuclear cells
in three chambers and in the compartment on the opposite
side of the filter from the mononuclear cells in the other
three chambers. Both compartments of each chamber were
brought to a final vol of 1.2 ml and a final serum concentration
of 15% with RPMI and serum.
To promote rapid passage of molecules from the compart-
ment on one side of the filter to the compartment on the
other side of the filter, the mounted chambers were attached
to a Nutator (Clay-Adams Div.) and rotated continuously for
the duration of the experiment. The entire apparatus was
placed in a 37°C incubator with a 5% C02-95% air atmosphere.
CFU in both compartments ofeach chamber were determined
daily; these culture determinations showed that L. pneu-
mophila did not cross the filter from one side of the chamber
to the other. At the end of each experiment, patency of the
six filters to small molecules and fluid was confirmed by
placing colored dye in the compartment on one side of each
chamber and observing its rapid appearance in the compart-
ment on the other side.
Sonication of mononuclear cells and L. pneumophila.
Leukocytes and/or L. pneumophila in tubes (held in an
ice-water bath) were sonicated with a micro tip, and infected
monocyte monolayers in petri dishes were sonicated with a
2.54 cm Diam high gain disrupter horn, attached to a sonicator
(Heat Systems-Ultrasonics, Inc., Plainview, N. Y.). Sonication
was performed under sterile conditions for 60 s continuously
with the output control of the sonicator set at the 4 position.
This amount of sonic energy lysed the leukocytes completely
(as determined by phase-contrast microscopy) but did not
reduce L. pneumophila CFU.
Directfluorescent antibody staining. Infected monocytes
in monolayers on coverslips were fixed in Diff-Quik fixative
(Harleco, American Hospital Supply Corp., Gibbstown, N. J.),
overlaid with 5-10 gld of fluorescein isothiocyanate-con-jugated rabbit anti-L. pneumophila Knoxville 1 (group 1)
antiserum, globulin fraction (provided by the Center for
Disease Control), placed in a covered chamber, incubated
for 20 min at 37°C, washed and incubated for 10 min at 220C
in phosphate-buffered saline (pH 7.6) (23), washed in water,
air dried, mounted in buffered glycerol (23), and examined
with a Zeiss fluorescent photomicroscope III (Carl Zeiss,
Inc., New York).
Electron microscopy studies. Monocyte monolayer cul-
tures were prepared by incubating 7 x 106 mononuclear cells
for 1 h in 2 ml RPMI and 15% serum in 35-mm plastic petri
dishes at 37°C in 5% C02-95% air, washing away nonadherent
leukocytes, and incubating the adherent cells for an additional
24 h in RPMI and 15% serum. The cultures were washed
with RPMI to remove nonadherent cells, and the adherent
cells were infected by incubating them for 1 h at 37°C with
7 x 106 CFU L. pneumophila in 2 ml RPMI and 15% serum
without shaking. The CFU:monocyte ratio was about 5:1 at
this time. The monolayers were then washed with RPMI to
remove noncell-associated bacteria, and incubated at 37°C
in 2 ml RPMI and 15% serum. At daily intervals, the infected
monolayers were fixed for electron microscopy with a solution
consisting of 1% OSO4 (two parts) and 2.5% glutaraldehyde
(one part) in 0.1 M cacodylate buffer, pH 7.4, stained with
0.25% uranyl acetate in 0.1 M sodium acetate buffer, pH 6.3,
dehydrated with ethanol, released from the surface of the
petri dishes with propylene oxide, and embedded in Epon
(Shell Chemical Co., Houston, Tex.) as described (29). The
sections were stained with lead citrate (30) and uranyl
acetate and examined with a Philips 300 electron microscope
(Philips Electronic Instruments, Inc., Mahwah, N. J.).
Safety precautions. All handling of infectious material,
such as that involved in inoculating and harvesting em-
bryonated hens' eggs, infecting and sonicating leukocytes,
transferring and diluting suspensions of organisms, and
plating organisms on agar was done in a biological safety
cabinet.
RESULTS
L. pneumophila multiplies in the presence of
monocytes. We incubated L. pneumophila with mono-
cytes in monolayer culture and washed away noncell-
adherent bacteria, as described in Fig. 1. We then
followed the course ofthe interaction between bacteria
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FIGURE 1 Course ofL. pneumophila infection of monocytes
as visualized by fluorescence microscopy. L. pneumophila
were incubated with 24-h explanted monocytes on glass
coverslips for 1 h at 37°C in 5% C02-95% air at a 5:1 ratio of
CFU:monocytes and nonadherent bacteria were washed
away. The monocytes were fixed, incubated with fluorescein-
conjugated rabbit anti-L. pneumophila antibody, and ex-
amined by fluorescence microscopy immediately after the
infection (A) and 4 d later at the peak of the infection (B).
x1200.
and monocytes by fluorescence microscopy and, in
parallel cultures, by disrupting and assaying the
cultures for CFU of L. pneumophila.
Few (<5%) of the monocytes examined immediately
after infection had bound or ingested L. pneumophila,
and these monocytes usually had only one cell-associ-
ated bacterium (Fig. 1A). Over the next few days, CFU
of L. pneumophila increased 4-5 logs, and by fluores-
cence microscopy, the number of monocytes contain-
ing L. pneumophila increased in parallel with bacterial
growth. At the peak of infection, monocytes appeared
packed full with organisms (Fig. 1B). Maximum growth
of L. pneumophila coincided with destruction of
the monocytes.
To infect a larger proportion of monocytes and
thereby increase the synchrony of infection, we incu-
bated L. pneumophila with mononuclear cells in
suspension on a gyratory shaker. We then plated the
infected monocytes on coverslips and washed away
nonadherent bacteria and leukocytes. By fluorescence
microscopy, nearly all the monocytes had cell-associ-
ated bacteria; on the average, they had 10 L. pneumo-
phila/monocyte. In monocyte cultures infected in this
way, CFU of L. pneumophila increased 3 log within
24-48 h (Fig. 2). The maximal log phase doubling
time of L. pneumophila in monocytes infected in
suspension was 114 min (Fig. 2), a rate of growth that
is twice as fast as that reported in specialized media
used to grow this fastidious organism (31, 32).
Control experiments showed that in the absence of
cells, L. pneumophila did not multiply in RPMI
alone, in RPMI containing 15% fresh human serum,
or in RPMI conditioned for 4 d by viable human
LL-
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FIGURE 2 Multiplication of L. pneumophila in association
with monocytes. L. pneumophila were incubated with
mononuclear cells in suspension at a 5:1 ratio of CFU:mono-
cytes at 37°C in 5% C02-95% air for 30 min on a gyratory
shaker. The monocytes were then plated on glass coverslips,
and non-adherent bacteria and leukocytes washed away. The
monocyte monolayers were incubated in 2 ml RPMI and 15%
serum and CFU in the medium determined at the indicated
times. Zero time is immediately after the nonadherent bacteria
and leukocytes were washed away.
monocytes. Fresh serum was present during L. pneu-
mophila infection of monocytes and, subsequently,
when L. pneumophila multiplied in these cultures;
these data indicate that L. pneumophila are resistant
to human serum. Other experiments, not reported here,
confirmed that egg yolk-grown L. pneumophila are not
killed by human serum even in the presence of high
titer anti-L. pneumophila antiserum.
L. pneumophila multiplies in the presence of mono-
cytes but not lymphocytes. The above experiments
show that L. pneumophila multiplies in the presence
of monocytes. To find out if the bacteria also multiply
in the presence of lymphocytes, we compared the
growth of L. pneumophila in the presence of the total
mononuclear cell population with growth in the
presence of monocytes and lymphocytes.
We added L. pneumophila (105 CFU) to petri dishes
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containing (a) 2.2 or 5 x 106 mononuclear cells (-40%
monocytes and 60% lymphocytes); (b) 2.2 x 106 mono-
cytes selected by adherence from 5 x 106 mononuclear
cells; and (c) 2.2 x 106 lymphocytes (nonadherent
mononuclear cells) selected from the same mono-
nuclear cell population as (b). We incubated the
cells at 37°C in 5% C02-95% air on a gyratory shaker
at 100 rpm for 3 h and under stationary conditions
thereafter. We sampled the medium of each petri dish
daily to determine the CFU of L. pneumophila in
each petri dish.
L. pneumophila multiplied only in cell populations
containing adherent cells (Fig. 3). It grew comparably
in the total mononuclear cell population and the
adherent (monocyte enriched) fraction of that popula-











cyte enriched) fraction. These findings indicate that L.
pneumophila grows in monocytes but not lymphocytes.
L. pneumophila growth is proportional to the
number of monocytes in the culture. The results of
the experiment described in Fig. 3 suggested that the
yield of L. pneumophila was proportional to the
number of mononuclear cells in the culture. To in-
vestigate this further, we varied the number of mono-
nuclear cells and the number of L. pneumophila
independently of each other. Peak growth of L. pneu-
mophila was independent of the number of bacteria
used to initiate the infection (Fig. 4A) but was propor-
tional to the concentration of mononuclear cells in the
culture (Fig. 4B). Since monocytes, but not lympho-
cytes, support the growth of L. pneumophila (Fig. 3),
these findings show that growth of this bacterium is
proportional to the number ofmonocytes in the culture.
In experiments where L. pneumophila were main-
tained with infected mononuclear cells after infection







FIGURE 3 L. pneumophila multiplies in the presence of
monocytes (adherent cells) but not lymphocytes (nonadherent
cells). L. pneumophila (105 CFU) were added to petri dishes
containing 2.2 ml RPMI, 15% serum, and (a) 2.2 or 5 x 106
mononuclear cells; (b) 2.2 x 106 adherent mononuclear cells
selected from 5 x 106 mononuclear cells; (c) 2.2 x 106 non-
adherent mononuclear cells selected from the same mono-
nuclear cell population as in (b). Adherent and nonadherent
mononuclear cells were selected as described in Methods.
The cultures were incubated at 37°C in 5% C02-95% air on a
gyratory shaker (100 rpm) for 3 h and under stationary
conditions thereafter. CFU of L. pneumophila in each petri
dish were determined daily. Each point represents the
average for three replicate petri dishes +SE.
FIGURE 4 L. pneumnophila growth is proportional to the
number of monocytes in the culture. (A) L. pneuntophila at
concentrations ranging from 3 x 103 to 3 x 106 CFU/ml, as
indicated, were incubated in tubes with a fixed number of
mononuclear cells (106/ml) in 2 ml RPMI and 15% serum.
The cultures were incubated at 37°C in 5% C02-95% air on a
gyratory shaker for 1 h and under stationary conditions
thereafter. CFU in each culture were determined daily. Each
point represents the average for three replicate tubes ±+SE.
(B) L. pneumophila at a concentration of 3 x 104 CFU/ml
were incubated in tubes with monocytes at concentrations
ranging from 2.5 x 105 to 4 x 106 mononuclear cells/ml, as
indicated, in 2 ml RPMI and 15% serum. The cultures were
incubated under the same conditions as in A. CFU were
determined daily. Each point represents the average for
three replicate tubes +SE.
Legionella pneumophila Multiplies Intracellularly in Human Monocytes 445






of mo~~nnonuclearcellsz103 I0 1 2 3 4 5 6 7Days after infection
FIGURE 5 L. pneumophila multiplies only in the presence
of intact leukocytes. L. pneumophila (-6 x 104 CFU) were
added to tubes containing 2 ml RPMI, 15% serum, and (a) 3
x 100 intact mononuclear cells; (b) 3 x 106 sonicated mono-
nuclear cells; or (c) 3 x 106 sonicated and 3 x 106 intact
mononuclear cells. The cultures were incubated at 370C in
5% C02-95% air on a gyratory shaker for 1 h and thereafter
under stationary conditions until 4 d after the start of the
experiment. At that time, 3 x 106 intact mononuclear cells
were added to tubes that initially contained L. pneumophila
and sonicated mononuclear cells. The cultures were shaken
again for 1 h and then incubated again at 370C under stationary
conditions. CFU were deterinined daily. Each point repre-
sents the average for three replicate tubes +SE.
multiplication; this lag was not seen when similarly
infected monocytes were plated and bacteria that were
not adherent to monocytes were washed away, as in
Fig. 2. The probable reason for the lag was that, early
after infection, a large number of nonmonocyte-ad-
herent (and nonreplicating) bacteria were in the
culture. These masked the contribution to total CFU
of the relatively small number of L. pneumophila that
had infected monocytes but had not yet multiplied to
a high level.
L. pneumophila multiplies only in the presence of
intact monocytes. To determine whether L. pneumo-
phila requires intact viable monocytes for growth,
we incubated the bacteria with intact mononuclear
cells and/or an equivalent number of sonically dis-
rupted mononuclear cells. L. pneumophila multiplied
only in cultures containing intact mononuclear cells
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FIGuRE 6 L. pneumophila requires intact monocytes for
multiplication at every phase of its growth. L. pneumophila
(-2 x 105 CFU) were added to tubes containing 3 x 106
intact mononuclear cells in 2 ml RPMI and 15% serum. The
cultures were incubated at 37°C in 5% C02-95% air on a
gyratory shaker for 1 h and under stationary conditions
thereafter. Every 12 or 24 h, three replicate cultures were
sonicated (arrow) and CFU determined thereafter. Each point
represents the average for three replicate tubes +SE.
cultures containing sonically disrupted mononuclear
cells 4 d after the start ofthe experiment, the remaining
live L. pneumophila then multiplied.
To see if L. pneumophila multiplies extracellularly
after an initial exposure to monocytes or after entering
the logarithmic phase ofgrowth in monocytes, we infected
replicate cultures of mononuclear cells and sonically
disrupted them at various intervals thereafter. (A
control experiment showed that the intensity of sonica-
tion used to disrupt the leukocytes did not inhibit
or slow the growth of L. pneumophila in monocytes
[data not shown].) The dashed line in Fig. 6 connects
points representing CFU in each set of cultures
immediately after sonication. It thus depicts the growth
curve of L. pneumophila in intact leukocytes. The
solid lines in Fig. 6 represent the CFU in each set
of cultures after sonication.
Regardless ofwhen in the growth phase we sonicated
the leukocytes, growth of L. pneumophila ceased and
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did not resume thereafter. Intact leukocytes were
thus required for multiplication of L. pneumophila
at every phase of its growth.
L. pneumophila multiplies only when in direct
contact with monocytes. Using parabiotic chambers,
we tested the possibility that L. pneumophila might
require not intact monocytes themselves but some
short-lived product produced by intact monocytes;
such a labile product would presumably be deficient
in medium conditioned by monocytes since L. pneumo-
phila does not grow in such conditioned medium. We
separated the two compartments of each chamber with
a filter that contained pores large enough to allow
ready passage of molecules but too small to allow pas-
sage of bacteria (0.3-0.9 /m Diam) or mononuclear
cells from one compartment to the other. We placed
mononuclear cells in one compartment of each of the
six chambers and L. pneumophila in the compartment
on the same side of the filter as the mononuclear cells
in three chambers and in the compartment on the op-
200,000 L.pneurwophi/l on same side
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FIGuRE 7 L. pneumophila multiplies only when in direct
contact with monocytes. The two compartments of each of
six parabiotic chambers were separated by 0.05-,um Nuclepore
filters, as described in Methods. Mononuclear cells (1.5
x 106) were placed in one compartment of each of the six
chambers. L. pneumophila (3 x 104) were placed in the same
compartment as the mononuclear cells in three chambers and
in the compartment on the opposite side of the filter from the
mononuclear cells in the other three chambers. Both com-
partments of each parabiotic chamber contained a total
volume of 1.2 ml RPMI and 15% serum. The chambers were
rotated continuously at 37°C in 5% C02-95% air. CFU were
determined daily. Each point represents the average for
three chambers +SE.
posite side of the filter from the mononuclear cells in
the other three chambers.
L. pneumophila multiplied only when placed on the
same side of the filter as the mononuclear cells (Fig. 7),
i.e., L. pneumophila multiplied only when in direct
contact with intact mononuclear cells.
L. pneumophila multiplies within membrane-bound
cytoplasmic vacuoles studded with structures re-
sembling host cell ribosomes. We examined mono-
cytes infected in a monolayer culture by electron
microscopy. Immediately after infection, we observed
no organisms in random ultrathin sections of adherent
monocytes, but after 2 or 3 d, we observed monocytes
that were full of bacteria (Fig. 8A). The bacteria were
found inside the monocytes and not on the surface.
All intracellular organisms were in membrane-bound
cytoplasmic vacuoles. In some monocytes, most of the
vacuoles contained one or two bacteria (Fig. 8B). In
other monocytes, a single large vacuole contained
numerous L. pneumophila (as many as 100 in one
section). The membranes of vacuoles containing one
bacterium were sometimes closely apposed to the
surface of the bacteria. The plasma and outer mem-
branes of these bacteria stained less intensely than
the vacuolar membrane, and could be distinguished
from it (Fig. 8B). Some bacteria appeared fixed in
the process of dividing.
Strikingly, the cytoplasmic sides of the membrane-
bound vacuoles surrounding the L. pneumophila
were studded with structures resembling monocyte
ribosomes (Fig. 8B). These structures were a feature
of vacuoles containing single or multiple numbers of
organisms. Occasionally, the vacuolar membrane sur-
rounding the L. pneumophila exhibited an outpocket-
ing that was lined with ribosomelike structures.
DISCUSSION
Our experiments show that L. pneumophila multiplies
intracellularly in human monocytes. Moreover, under
tissue culture conditions, this bacterium multiplies
only intracellularly. L. pneumophila can multiply
extracellularly on complex media. Thus this bacterium
is a facultative intracellular parasite. As such, it falls
into a select category of bacterial pathogens that can
evade host defenses by parasitizing monocytes. Other
members of this category are Listeria monocytogenes
and the mycobacteria including Mycobacterium tuber-
culosis and Mycobacterium leprae.
Two groups of investigators, studying other cell
types, have recently reported findings consistent with
ours. Daisy et al. (33) have reported that agar-adapted
L. pneumophila grow in the presence of MRC-5, HeLa,
Hep 2, and McCoy cells in tissue culture medium and
that L. pneumophila can be recognized within the
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FIGuRE 8 Electron micrographs of monocytes infected with L. pneumophila. Monocytes in a
monolayer culture in plastic petri dishes were infected with L. pneumophila as in Fig. 1A, incu-
bated in RPMI and 15% serum at 37°C for 2 d, fixed in glutaraldehyde and osmium, and processed
for electron microscopy. (A) Monocyte heavily infected with L. pneumophila. xS,400. (B)
L. pneumophila in vacuoles studded with ribosomelike structures. Each vacuole contains two
bacilli. The ribosomelike structures (arrows) appear to be separated from the cytoplasmic face
of the vacuolar membrane by a gap of -100 A. Numerous 10-nm filaments in longitudinal and
cross-section (arrowhead) are visible in the monocyte cytoplasm. Note that their diameter is
smaller than that of the ribosomelike structures. x32,400.
cytoplasm of infected MRC-5 cells by transmission
electron microscopy. Kishimoto et al. (34) have re-
ported that cynolmolgus monkey alveolar macrophages
infected in vitro with agar-adapted L. pneumophila
contain few organisms at 3 h but are packed full with
organisms at 24 h after infection; their electron micro-
graphs of heavily infected monkey alveolar macro-
phages bear a striking resemblance to our micro-
graphs of heavily infected human monocytes.
We have no direct information regarding the mecha-
nism of entry of L. pneumophila into the monocyte's
cytoplasm. It seems likely that the bacteria are phago-
cytosed. After gaining entry, L. pneumophila resists
monocyte microbicidal systems by as yet unknown
mechanisms. Other intracellular parasites resist these
systems by a variety of strategies. M. tuberculosis
(35, 36) and Toxoplasma gondii (37) among others (38)
interfere with host phagosomelysosome fusion. Myco-
bacterium lepraemurium (39), M. tuberculosis (40),
Leishmania mexicana (41), and Leishmania donovani
(42) are able to thrive within the normally inhospitable
milieu of the phagolysosome. Whether phagosomes
containing L. pneumophila fuse with monocyte lyso-
somes is also unknown.
L. pneumophila that have multiplied within human
monocytes are found in membrane-bound cytoplasmic
vacuoles. A remarkable feature of these vacuoles is
that they are studded with structures resembling host
cell ribosomes. This morphologic feature has also been
noted on electron microscopic examination of leuko-
cytes in human lung tissue specimens from patients
with Legionnaires' disease (43). L. pneumophila is
evidently unique among bacterial pathogens in pro-
moting the formation of these vacuoles. The origin
of these vacuoles and their role in L. pneumophila
growth remain to be elucidated.
The roles of humoral and cellular immunity in host
defense against L. pneumophila also remain to be
determined. We have found that egg yolk-grown
L. pneumophila are resistant to killing by complement
even in the presence of anti-L. pneumophila antibody
and are inefficiently killed by human polymorpho-
nuclear leukocytes in the presence of anti-L. pneu-
mophila antibody and serum. These results, viewed
in conjunction with the increased incidence of L.
pneumophila infections in immunosuppressed pa-
tients (14-16), suggest that cell-mediated immunity
may play an important role in host defense against
L. pneumophila as it does against other intracellular
parasites.
Lymphokines produced by sensitized lymphocytes
have been shown to confer on animal macrophages
or human monocytes enhanced ability to resist or kill
M. tuberculosis (44, 45), L. monocytogenes (46-49),
Leishmania enrietti (50), T. gondii (51-56), and
Trypanosoma cruzi (57, 58). Lymphokine-activated
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macrophages may play a similar role in eradicating
L. pneumophila in vivo.
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